Press Releases
Samsung Biologics participates in CPHI Worldwide 2022
Samsung Biologics is attending CPHI Worldwide 2022 in Frankfurt, Germany from November 1 to 3, hosting one of the largest booths to cater client meetings and showcase its capabilities and business growth.
The company’s new marketing message - “Accelerating Excellence” - will be featured for the first time at the event, reflecting Samsung Biologics’ commitment to innovative speed, uncompromising quality, and tailored solutions.
Samsung Biologics will also be participating in two speaking sessions at CPHI this year. Kevin Sharp VP, Head of Global Sales Strategic Operations, will be sharing his insights on key considerations in choosing a CDMO partner on November 1, and James Choi EVP, Chief Information & Marketing Officer, on the importance of partnering with CDMO companies for a sustainable future on November 2.
To get in touch or to find out more about the speaking sessions, visit here.
Samsung Biologics is attending CPHI Worldwide 2022 in Frankfurt, Germany from November 1 to 3, hosting one of the largest booths to cater client meetings and showcase its capabilities and business growth.
The company’s new marketing message - “Accelerating Excellence” - will be featured for the first time at the event, reflecting Samsung Biologics’ commitment to innovative speed, uncompromising quality, and tailored solutions.
Samsung Biologics will also be participating in two speaking sessions at CPHI this year. Kevin Sharp VP, Head of Global Sales Strategic Operations, will be sharing his insights on key considerations in choosing a CDMO partner on November 1, and James Choi EVP, Chief Information & Marketing Officer, on the importance of partnering with CDMO companies for a sustainable future on November 2.
To get in touch or to find out more about the speaking sessions, visit here.